Consolidated Statements of Operations Statement (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
REVENUE:
Services	$ 188,735	$ 182,481
Product sales	74,168	78,446
Total revenue	262,903	260,927
OPERATING EXPENSES:
Cost of services, exclusive of depreciation expense shown below	110,571	110,153
Cost of product sales, exclusive of depreciation expense shown below	51,098	53,492
General and administrative expenses, exclusive of depreciation expense shown below	10,519	12,809
Depreciation	6,342	5,723
Amortization	291	302
Other (income) expense, net	1,255	(589)
OPERATING INCOME	82,827	79,037
Interest expense	2,363	2,269
Income before income tax expense	80,464	76,768
Income tax expense	19,311	20,036
Net income	61,153	56,732
Net income (loss) attributable to non-controlling interests	89	216
Net income attributable to Core Laboratories N.V.	$ 61,064	$ 56,516
EARNINGS PER SHARE INFORMATION:
Basic earnings per share attributable to Core Laboratories N.V. (in dollars per share)	$ 1.36	$ 1.22
Diluted earnings per share attributable to Core Laboratories N.V. (in dollars per share)	$ 1.35	$ 1.22
Cash dividends per share (in dollars per share)	$ 0.5	$ 0.32
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	44,908	46,201
Diluted	45,182	46,493